Market Overview

Benzinga's Top Upgrades

Share:
Benzinga's Top Upgrades
Related MCD
Debunking Myths About The Crisis In Venezuela: An Insider's Perspective
Top Chefs Choose Their Favorite Fast Food
Top 10 Health Care Stocks: Which To Buy? Part 3 (Seeking Alpha)
Related AET
Goldman Adds Cigna To Conviction Buy List, Expects DoJ Announcement To Refocus Investors On Standalone Merits
JPMorgan Downgrades Humana Following Deal Reports
Week In Review: Stock Breakouts, Netflix Subs Snub, Tesla's Plan, M&A News (Investor's Business Daily)

Analysts at Morgan Stanley upgraded McDonald's (NYSE: MCD) from “equal-weight” to “overweight.” The target price for McDonald's has been raised from $93 to $115. McDonald's shares closed at $95.41 yesterday.

Credit Suisse upgraded Aetna (NYSE: AET) from “neutral” to “outperform.” The target price for Aetna has been raised from $69 to $83. Aetna's shares closed at $69.14 yesterday.

Analysts at Bank of America upgraded E.I. du Pont de Nemours and Company (NYSE: DD) from “neutral” to “buy.” The target price for DuPont has been raised from $64 to $70. DuPont's shares closed at $63.13 yesterday.

BMO Capital upgraded Macy's (NYSE: M) from “market perform” to “outperform.” The target price for Macy's has been raised from $53 to $70. Macy's shares closed at $51.84 yesterday.

Latest Ratings for MCD

DateFirmActionFromTo
Jun 2016BairdMaintainsNeutral
Jun 2016Credit SuisseMaintainsOutperform
Jun 2016NomuraDowngradesBuyNeutral

View More Analyst Ratings for MCD
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (AET + DD)

View Comments and Join the Discussion!